• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    BioAmber Will Start Trading on the TSX

    Bryan Mc Govern
    May. 03, 2017 08:22AM PST
    Biotech Investing

    BioAmber announced it will begin trading on the TSX under the symbol BIOA starting May 3, 2017.

    BioAmber (NYSE:BIOA) announced it will officially be trading on the TSX under the symbol BIOA starting May 3, 2017.
    As quoted in the press release:

    BioAmber’s previously issued special warrant (the “Special Warrant“) was automatically exercised, on April 28, 2017, for 2,224,199 Common Shares (the “Underlying Shares“) following the issuance of a receipt for its final prospectus qualifying the Underlying Shares by the British Columbia Securities Commission.
    The Special Warrant was issued in a private placement on December 30, 2016, at a price of US$4.00 per Underlying Share issuable upon the exercise of the Special Warrant, resulting in gross proceeds to the Company of US$8,896,796. The proceeds were placed in escrow and were released to the Company concurrently with the automatic exercise of the Special Warrant.

    Click here to read the full press release.

    Source: www.newswire.ca

    private placementbritish columbia securitiesbritish columbia
    The Conversation (0)

    Go Deeper

    AI Powered
    BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer

    BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer

    BluEnrgies Ltd.  Announces Closing of Reverse Takeover Transaction

    BluEnrgies Ltd. Announces Closing of Reverse Takeover Transaction

    Latest News

    Seegnal Inc. Announces Extension of Maccabi Health Services Contract

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×